Jul 27, 2026 05:32PM
Jul 15, 2026 01:13PM
Jul 15, 2026 01:13PM
May 22, 2026 03:59PM
May 7, 2026 07:00AM
Feb 26, 2026 07:00AM
Nov 6, 2025 07:02AM Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update
Nov 6, 2025 07:00AM
Sep 24, 2025 04:51AM
Sep 24, 2025 01:00AM
Aug 6, 2025 07:00AM
Jul 22, 2025 09:13AM
Jul 22, 2025 08:55AM
Jul 22, 2025 07:00AM Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D
Jul 22, 2025 07:00AM
May 7, 2025 07:00AM
May 6, 2025 04:01PM
May 6, 2025 04:01PM
Apr 1, 2025 09:01AM
Apr 1, 2025 09:00AM
Feb 26, 2025 07:00AM Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance
Feb 15, 2025 10:00PM
Jan 28, 2025 06:15AM
Jan 28, 2025 06:00AM
Jan 21, 2025 06:00PM
Jan 13, 2025 12:08AM
Jan 13, 2025 12:05AM
Nov 6, 2024 07:00AM Lantheus Reports Third Quarter 2024 Financial Results
Sep 5, 2024 08:33AM
Sep 5, 2024 08:30AM
Jul 31, 2024 07:00AM
Jul 15, 2024 08:31AM
Jul 15, 2024 08:30AM
Jun 27, 2024 07:05AM
Jun 27, 2024 07:05AM Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers
May 2, 2024 07:00AM
Mar 5, 2024 08:06AM
Mar 5, 2024 08:00AM
Feb 22, 2024 07:00AM
Jan 23, 2024 07:45AM
Jan 23, 2024 07:45AM
Jan 9, 2024 08:07AM Perspective Therapeutics (CATX) Enters into Strategic Agreements with Lantheus (LNTH) Including Equity Investment, Co-Development Options
Jan 9, 2024 08:02AM
Jan 9, 2024 08:00AM
Jan 9, 2024 08:00AM
Jan 9, 2024 07:55AM
Jan 9, 2024 07:55AM
Dec 18, 2023 07:33AM
Dec 18, 2023 07:30AM Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
Nov 2, 2023 07:00AM

1,171,638 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All